NasdaqCM - Nasdaq Real Time Price USD
INmune Bio, Inc. (INMB)
8.24
+0.40
+(5.10%)
At close: April 23 at 4:00:01 PM EDT
7.97
-0.27
(-3.28%)
Pre-Market: 4:20:52 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 6.35M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MOSS DAVID J. Chief Financial Officer | Purchase at price 5.29 per share. | Direct | 52,868 | Sep 30, 2024 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Purchase at price 6.38 per share. | Direct | 98,048 | Sep 12, 2024 |
| MOSS DAVID J. Chief Financial Officer | Purchase at price 6.38 per share. | Direct | 49,024 | Sep 12, 2024 |
| JUDA SCOTT Director | Purchase at price 7.27 per share. | Indirect | 36,350 | Jun 25, 2024 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Stock Award(Grant) at price 8.32 per share. | Direct | 149,993 | Apr 19, 2024 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Purchase at price 8.32 per share. | Direct | 149,993 | Apr 19, 2024 |
| MOSS DAVID J. Chief Financial Officer | Stock Award(Grant) at price 8.32 per share. | Direct | 149,993 | Apr 19, 2024 |
| MOSS DAVID J. Chief Financial Officer | Purchase at price 8.32 per share. | Direct | 149,993 | Apr 19, 2024 |
| LOWDELL MARK WILLIAM Officer and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 8.32 per share. | Direct | 119,999 | Apr 19, 2024 |
| LOWDELL MARK WILLIAM Officer and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.32 per share. | Direct | 119,999 | Apr 19, 2024 |
| JUDA SCOTT Director | Stock Award(Grant) at price 8.32 per share. | Direct | 246,297 | Apr 19, 2024 |
| JUDA SCOTT Director | Purchase at price 8.32 per share. | Direct | 246,297 | Apr 19, 2024 |
| JUDA SCOTT Director | Purchase at price 6.95 per share. | Indirect | 48,650 | Nov 10, 2023 |
| SCHROEDER TIMOTHY J Director | Sale at price 11.01 per share. | Indirect | 110,085 | Jul 12, 2023 |
| MOSS DAVID J. Chief Financial Officer | Purchase at price 6.42 per share. | Direct | 16,062 | Mar 17, 2023 |
| MOSS DAVID J. Chief Financial Officer | Purchase at price 6.27 - 6.79 per share. | Direct | 68,649 | May 27, 2022 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Purchase at price 6.41 per share. | Direct | 40,383 | May 26, 2022 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Stock Award(Grant) at price 8.43 per share. | Direct | 199,993 | Mar 22, 2022 |
| MOSS DAVID J. Chief Financial Officer | Stock Award(Grant) at price 8.43 per share. | Direct | 149,995 | Mar 22, 2022 |
| LOWDELL MARK WILLIAM Officer and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 8.43 per share. | Direct | 198,864 | Mar 22, 2022 |
| GANJEI JAMES KELLY Director | Stock Award(Grant) at price 8.43 per share. | Direct | 149,995 | Mar 22, 2022 |
| JUDA SCOTT Director | Purchase at price 13.55 per share. | Indirect | 33,875 | Nov 17, 2021 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Sale at price 20.00 per share. | Direct | 72,520 | Nov 3, 2021 |
| MOSS DAVID J. Chief Financial Officer | Sale at price 20.00 per share. | Direct | 20,500 | Nov 3, 2021 |
| LOWDELL MARK WILLIAM Officer and Beneficial Owner of more than 10% of a Class of Security | Sale at price 20.00 per share. | Direct | 14,020 | Nov 3, 2021 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Sale at price 20.00 per share. | Direct | 130,340 | Oct 27, 2021 |
| MOSS DAVID J. Chief Financial Officer | Sale at price 20.00 per share. | Direct | 41,580 | Oct 27, 2021 |
| LOWDELL MARK WILLIAM Officer and Beneficial Owner of more than 10% of a Class of Security | Sale at price 20.00 per share. | Direct | 47,140 | Oct 27, 2021 |
| MOSS DAVID J. Chief Financial Officer | Sale at price 20.00 per share. | Direct | 23,100 | Oct 25, 2021 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Sale at price 20.00 per share. | Direct | 472,320 | Oct 22, 2021 |
| LOWDELL MARK WILLIAM Officer and Beneficial Owner of more than 10% of a Class of Security | Sale at price 20.00 per share. | Direct | 8,000 | Oct 22, 2021 |
| XENCOR INC Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 7.80 per share. | Direct | 842,400 | Sep 3, 2021 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Conversion of Exercise of derivative security at price 3.91 per share. | Direct | 117,300 | Aug 25, 2021 |
| MOSS DAVID J. Chief Financial Officer | Conversion of Exercise of derivative security at price 3.91 per share. | Direct | 97,750 | Jul 16, 2021 |
| SCHROEDER TIMOTHY J Director | Sale at price 27.63 per share. | Indirect | 400,082 | Jul 13, 2021 |
| SCHROEDER TIMOTHY J Director | Sale at price 23.20 per share. | Indirect | 696,150 | Jul 9, 2021 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Sale at price 20.02 - 20.08 per share. | Direct | 602,050 | Jul 8, 2021 |
| MOSS DAVID J. Chief Financial Officer | Sale at price 20.01 - 20.09 per share. | Direct | 501,523 | Jul 8, 2021 |
| LOWDELL MARK WILLIAM Officer | Sale at price 20.02 - 20.19 per share. | Direct | 604,706 | Jul 8, 2021 |
| SCHROEDER TIMOTHY J Director | Sale at price 19.02 per share. | Indirect | 190,200 | Jun 14, 2021 |
| SCHROEDER TIMOTHY J Director | Sale at price 17.01 per share. | Indirect | 170,054 | Jun 10, 2021 |
| SCHROEDER TIMOTHY J Director | Sale at price 11.95 per share. | Indirect | 119,496 | Mar 31, 2021 |
| POWERS LINDA F Beneficial Owner of more than 10% of a Class of Security | Sale at price 4.60 per share. | Direct | 1,012,000 | Jan 27, 2020 |
| LOWDELL MARK WILLIAM Officer and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.23 per share. | Direct | 18,179 | Sep 11, 2019 |
| JUDA SCOTT Director | Purchase at price 6.00 per share. | Indirect | 30,000 | Aug 21, 2019 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Purchase at price 5.92 - 6.03 per share. | Direct | 11,987 | Aug 20, 2019 |
| MOSS DAVID J. Chief Financial Officer | Purchase at price 5.65 per share. | Direct | 16,950 | Aug 20, 2019 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Purchase at price 6.91 - 7.20 per share. | Direct | 14,058 | Aug 9, 2019 |
| TESI RAYMOND JOSEPH Chief Executive Officer | Purchase at price 10.35 per share. | Direct | 103,500 | Jun 3, 2019 |
| MOSS DAVID J. Chief Financial Officer | Purchase at price 10.35 per share. | Direct | 103,500 | Jun 3, 2019 |
Related Tickers
COYA Coya Therapeutics, Inc.
6.56
-1.20%
BDTX Black Diamond Therapeutics, Inc.
1.5800
+1.28%
GANX Gain Therapeutics, Inc.
1.8500
0.00%
AKRO Akero Therapeutics, Inc.
39.61
+2.88%
LXEO Lexeo Therapeutics, Inc.
3.3700
-1.46%
CMPX Compass Therapeutics, Inc.
2.0700
+4.55%
AVXL Anavex Life Sciences Corp.
9.31
+1.09%
ANVS Annovis Bio, Inc.
1.5100
+2.72%
ABEO Abeona Therapeutics Inc.
5.22
-1.14%
CRDF Cardiff Oncology, Inc.
2.9400
-3.61%